Ofloxacin

Ofloxacinum

For medical students2 min readUpdated 2026-10-10

Ofloxacin is a systemic antimicrobial agent with basic pharmacological properties closely related to ciprofloxacin. In clinical practice, it is highly valued for its outstanding bioavailability, ability to cross the blood-brain barrier, efficacy against a wide range of infections, and availability as ophthalmic topical preparations.

BioavailabilityExceeds 96%, with rapid and nearly complete intestinal absorption (up to 95%).

DistributionCharacterized by high tissue permeability and crosses the blood-brain barrier.

SpectrumHighly active against Chlamydia and pneumococci, but completely inactive against anaerobes.

Dosing regimenAdministered 1–2 times daily; available for oral and intravenous administration.

Antimicrobial Spectrum and Limitations

Ofloxacin shares properties that make it very similar to ciprofloxacin; however, proper clinical use requires a clear understanding of the differences in their antimicrobial activity.

Key differences from ciprofloxacin:

Enhanced efficacy: The agent demonstrates higher activity against Streptococcus pneumoniae and intracellular pathogens, particularly Chlamydia species.
Reduced efficacy: Ofloxacin is less active against Pseudomonas aeruginosa, making it a second-choice drug when this infection is suspected.

Strict spectrum limitations:

The drug is completely ineffective against all anaerobic microflora. This list includes Bacteroides species, Fusobacterium species, and Clostridium difficile.
It lacks any activity against Treponema pallidum, the causative agent of syphilis.

Pharmacokinetic Profile

The pharmacokinetics of ofloxacin feature high values, ensuring reliability and predictability in systemic antibacterial therapy.

Absorption and bioavailability: When administered orally, the drug is absorbed rapidly and almost completely (up to 95%). Total bioavailability exceeds 96%. This means that blood concentrations following oral administration are virtually identical to those achieved via intravenous infusion.
Distribution: Ofloxacin is characterized by high tissue penetration and actively accumulates in various biological fluids. A critical pharmacological property is its ability to cross the blood-brain barrier (BBB), allowing it to reach central nervous system tissues.
Dosing regimen: Due to stable pharmacokinetics and sustained therapeutic concentrations, administration 1–2 times daily is sufficient. Both oral and intravenous routes are available.

Clinical Use in Systemic Therapy

Ofloxacin is widely used to treat infectious and inflammatory diseases of various localizations, as well as for prophylaxis.

Respiratory tract and ENT organs: Prescribed for pneumonia, acute exacerbations of bronchitis, and bacterial infections of the upper respiratory tract and ear (sinusitis, otitis media, pharyngitis, tracheitis).
Genitourinary system: Highly effective for kidney and urinary tract infections (pyelonephritis, cystitis, urethritis). It is also used to treat specific sexually transmitted infections, including gonorrhea and bacterial prostatitis.
Other localizations: Includes therapy for skin, soft tissue, bone, and joint infections, as well as intra-abdominal and pelvic inflammatory processes.
Specific therapy: Ofloxacin is routinely included in combination regimens for drug-resistant forms of tuberculosis.
Surgical prophylaxis: The drug is successfully used to prevent bacterial complications in the postoperative period.

Ophthalmic Practice

In addition to its systemic effects, ofloxacin is valuable for the topical treatment of bacterial eye infections. In ophthalmology, it is prescribed as topical formulations such as eye drops or eye ointment.

Main indications for topical use include:

Bacterial conjunctivitis
Blepharitis
Keratitis

Mnemonic

To easily remember ofloxacin's spectrum compared to ciprofloxacin, use the "C&P" rule: Chlamydia and Pneumococci are treated better; Pseudomonas is treated worse. Simply forget about anaerobes and Treponema—it has no effect on them.

Frequently asked questions

What is the antimicrobial mechanism of action of ofloxacin?

The antimicrobial mechanism of ofloxacin, a fluoroquinolone, involves the inhibition of bacterial topoisomerases (DNA gyrase and topoisomerase IV). The drug exhibits high selective toxicity with low toxicity to the host organism, because suppressing human topoisomerase II requires extremely high (non-therapeutic) concentrations.

Mechanisms of microbial resistance to the drug include:

Target modification — chromosomal mutations in genes encoding topoisomerases.
Reduced membrane permeability — downregulation of porin expression.
Active drug efflux — Upregulation of efflux pumps.

What is the main difference between ofloxacin and ciprofloxacin?

Ofloxacin has higher activity against pneumococci and chlamydia, but is inferior to ciprofloxacin against Pseudomonas aeruginosa. Otherwise, their pharmacological profiles are very similar.

Does the drug penetrate the central nervous system?

Yes, one of the key pharmacokinetic features of ofloxacin is its ability to cross the blood-brain barrier (BBB) and accumulate in various tissues and body fluids.

Is ofloxacin effective against anaerobic infections?

No, the drug has strict spectrum limitations. It is completely ineffective against all anaerobic flora, including Bacteroides, Fusobacterium, and Clostridium difficile.

How is ofloxacin used in surgical practice?

In surgery, the drug is administered prophylactically. Its primary goal is the prevention of bacterial infectious complications during the postoperative period.

Go deeper

Comparative analysis of antimicrobial activity: ofloxacin versus ciprofloxacin.
Pharmacokinetic features: mechanisms of intestinal absorption and blood-brain barrier penetration.
The role of ofloxacin in combination therapy for drug-resistant tuberculosis.
Topical ophthalmology: treatment of bacterial keratitis, blepharitis, and conjunctivitis.
Prevention of postoperative infectious complications using systemic antibiotic therapy.